chr4-99608827-G-A
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_001386140.1(MTTP):c.1619G>A(p.Arg540His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000409 in 1,613,968 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001386140.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTTP | NM_001386140.1 | c.1619G>A | p.Arg540His | missense_variant | 12/18 | ENST00000265517.10 | NP_001373069.1 | |
MTTP | NM_000253.4 | c.1619G>A | p.Arg540His | missense_variant | 13/19 | NP_000244.2 | ||
MTTP | NM_001300785.2 | c.1370G>A | p.Arg457His | missense_variant | 12/18 | NP_001287714.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTTP | ENST00000265517.10 | c.1619G>A | p.Arg540His | missense_variant | 12/18 | 1 | NM_001386140.1 | ENSP00000265517.5 | ||
MTTP | ENST00000457717.6 | c.1619G>A | p.Arg540His | missense_variant | 13/19 | 5 | ENSP00000400821.1 | |||
MTTP | ENST00000511045.6 | c.1370G>A | p.Arg457His | missense_variant | 12/18 | 2 | ENSP00000427679.2 | |||
ENSG00000248676 | ENST00000508578.1 | n.128+12060C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251154Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135724
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461824Hom.: 0 Cov.: 32 AF XY: 0.0000358 AC XY: 26AN XY: 727208
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74326
ClinVar
Submissions by phenotype
Abetalipoproteinaemia Pathogenic:4Other:1
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Aug 03, 2017 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 22, 1996 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 18, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 16, 2022 | Variant summary: MTTP c.1619G>A (p.Arg540His) results in a non-conservative amino acid change located in the Vitellogenin, N-terminal (IPR039988) of the encoded protein sequence, specifically within the alpha-helical region (Khatun_2013). Another missense variant affecting the same amino acid has been classified as likely pathogenic by our laboratory (c.1618C>T, p.Arg540Cys), providing moderate evidence of pathogenicity. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251154 control chromosomes. c.1619G>A has been reported in the literature in individuals affected with Abetalipoproteinaemia (Rehberg_1996, Wang_2000, Di Filippo_2019), with evidence of co-segregation in two families. Some individuals are reported as compound heterozygous, carrying other variants in trans likely to be pathogenic. These data indicate that the variant is likely to be associated with disease. At least two publications reports experimental evidence evaluating an impact on protein function, showing R540H loses phospholipid and triglyceride transfer activities and the ability to support apoB secretion (Rehberg_1996, Khatun_2013). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, both classifying the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:3
Likely pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 06, 2024 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 540 of the MTTP protein (p.Arg540His). This variant is present in population databases (rs199422220, gnomAD 0.003%). This missense change has been observed in individual(s) with abetalipoproteinemia (PMID: 8939939, 10679949, 30522860). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 14238). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MTTP protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects MTTP function (PMID: 8939939, 23475612). This variant disrupts the p.Arg540 amino acid residue in MTTP. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 25108285, 27578136). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at